Patient who Received First-ever Modified Pig Kidney Transplant Dies

The world’s first recipient of a genetically-modified pig kidney transplant, Rick Slayman, has passed away nearly two months after the historic operation. Massachusetts General Hospital, which conducted the pioneering surgery, confirmed Mr. Slayman’s demise.

The 62-year-old, who had been battling end-stage kidney disease, underwent the unprecedented procedure in March. The transplantation marked a significant advancement in xenotransplantation, offering hope as a potential solution to the global organ shortage crisis.

Despite the setback, the hospital emphasized that Mr. Slayman’s death was not associated with the transplant itself. In a statement, his family expressed deep sadness over his passing but also gratitude for the additional time they were able to spend with him following the procedure.

The pig kidney used in the transplant had been genetically engineered to remove harmful pig genes and incorporate specific human genes, aimed at enhancing compatibility with human recipients. Additionally, scientists had deactivated porcine endogenous retroviruses in the donor pig to eliminate any potential risk of infection in humans.

While mourning Mr. Slayman’s loss, the medical community hailed his contribution to advancing xenotransplantation. The hospital praised his courage and willingness to participate in groundbreaking research that could benefit countless transplant patients worldwide.

As investigations continue into the circumstances surrounding Mr. Slayman’s death, his legacy as a beacon of hope in the field of xenotransplantation will endure.